Nutritional management of cholestatic syndromes in childhood

Annales Nestle

Volumn 66, Issue 3, 2008, Pages 137-147

  Socha, Piotr ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Enteral nutrition; Lipid soluble vitamins; Liver disease; Liver failure; Malnutrition; Parenteral nutrition; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOPHEROL SUCCINATE; ARACHIDONIC ACID; BETA CAROTENE; CALCIFEDIOL; CALCIUM; CHOLESTEROL; DOCOSAHEXAENOIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IRON; LIPID; LIPID PEROXIDASE; LIPOPROTEIN X; LONG CHAIN FATTY ACID; LONG CHAIN TRIACYLGLYCEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDIUM CHAIN TRIACYLGLYCEROL; PHYTOMENADIONE; POLYUNSATURATED FATTY ACID; PROTEIN; RETINOL; SELENIUM; TOCOFERSOLAN; VITAMIN D; ZINC PHOSPHATE;

ALAGILLE SYNDROME; ALPHA TOCOPHEROL DEFICIENCY; ANEMIA; ASCORBIC ACID DEFICIENCY; BILE DUCT ATRESIA; BLEEDING; BONE DENSITY; BONE LESION; BRAIN PSEUDOTUMOR; CALORIC INTAKE; CARBOHYDRATE INTAKE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CYANOCOBALAMIN DEFICIENCY; DIET THERAPY; DRUG MEGADOSE; ENERGY RESOURCE; ESSENTIAL FATTY ACID DEFICIENCY; FOLIC ACID DEFICIENCY; HUMAN; HYPERAMMONEMIA; HYPERCALCEMIA; INTRAHEPATIC CHOLESTASIS; IRON DEFICIENCY; LIPID METABOLISM; LIPID PEROXIDATION; LIVER FAILURE; LIVER FIBROSIS; LIVER TRANSPLANTATION; MALNUTRITION; MINERAL DEFICIENCY; NUTRITIONAL ASSESSMENT; NUTRITIONAL REQUIREMENT; NUTRITIONAL STATUS; OBSTRUCTIVE JAUNDICE; OSTEOPOROSIS; PARENTERAL NUTRITION; PROGNOSIS; PROTEIN CALORIE MALNUTRITION; PROTEIN INTAKE; PROTEIN RESTRICTION; PYRIDOXINE DEFICIENCY; RETINOL DEFICIENCY; REVIEW; RICKETS; SCURVY; SELENIUM DEFICIENCY; STEATORRHEA; THIAMINE DEFICIENCY; TREATMENT CONTRAINDICATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN K DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 54249153712     PISSN: 05178606     EISSN: 16614011     Source Type: Journal    
DOI: 10.1159/000147411     Document Type: Review

References (59)

1. Ijland MM, Pereira RR, Cornelissen EAM: Incidence of late vitamin K deficiency bleeding in newborns in the Netherlands in 2005: evaluation of the current guideline. Eur J Pediatr 2008;167:165-169.
2. Chin SE, Shepherd RW, Thomas BJ, et al: The nature of malnutrition in children with end-stage liver disease awaiting orthotopic liver transplantation. Am J Clin Nutr 1992;56:164-168.
3. Baker A, Stevenson R, Dhawan A, et al: Guidelines for nutritional care for infants with cholestatic liver disease before liver transplantation. Pediatr Transplant 2007;11:825-834.
4. Samonte V, Sherman P, Taylor G, et al: Scurvy diagnosed in a paediatric liver transplant patient awaiting combined kidney and liver transplantation. Pediatr Transplant 2008;12:363-367.
5. Socha P, Litwin M: Editorial to: Scurvy diagnosed in a pediatric liver transplant awaiting combined kidney and liver transplantation. Pediatr Transplant 2008;12:257-260.
6. Heymsfield SB, Waki M, Reinus J: Are patients with chronic liver disease hypermetabolic? Hepatology 1990;11:502-505.
7. Greer R, Lehnert M, Lewindon P, et al: Body composition and components of energy expenditure in children with end-stage liver disease. J Pediatr Gastroenterol Nutr 2003;36:358-363.
8. Holt RI, Miell JP, Jones JS, et al: Nasogastric feeding enhances nutritional status in paediatric liver disease but does not alter circulating levels of IGF-I and IGF-binding proteins. Clin Endocrinol 2000;52:217-224.
9. Walkowiak J, Jankowska I, Pawlowska J, et al: Exocrine pancreatic function in children with progressive familial intrahepatic cholestasis type 2. J Pediatr Gastroenterol Nutr 2006;42:416-418.
10. Nagasaka H, Yorifuji T, Egawa H, et al: Evaluation of risk for atherosclerosis in Alagille syndrome and progressive familial intrahepatic cholestasis: two congenital cholestatic diseases with different lipoprotein metabolisms. J Pediatr 2005;146:329-335.
11. Sokol RJ, Stall C: Anthropometric evaluation of children with chronic liver disease. Am J Clin Nutr 1990;52:203-208.
12. Trocki O, Wotton MJ, Cleghorn GJ, Shepherd RW: Value of total body potassium in assessing the nutritional status of children with end-stage liver disease. Ann NY Acad Sci 2000;904:400-405.
13. Chongsrisawat V, Ruttanamongkol P, Chaiwatanarat T, et al: Bone density and 25-hydroxyvitamin D level in extrahepatic biliary atresia. Pediatr Surg Int 2001;17:604-608.
14. Graham GG, MacLean WC, Brown KH, et al: Protein requirements of infants and children: growth during recovery from malnutrition. Pediatrics 1996;97:499-505.
15. Tomkins A, Garlick PJ, Schofield WN, Waterlow JC: The combined effect of infection and malnutrition on protein metabolism in children. Clin Sci 1983;65:313-324.
16. Sokal EM, Baudoux MC, Collette E, et al: Branched chain amino acids improve body composition and nitrogen balance in a rat model of extra-hepatic biliary atresia. Pediatr Res 1996;40:66-71.
17. Chin SE, Shepherd RW, Thomas BJ, et al: The nature of malnutrition in children with end-stage liver disease awaiting orthotopic liver transplantation. Am J Clin Nutr 1992;56:164-168.
18. Koletzko B, Demmelmair H, Socha P: Nutritional support of infants and children: supply and metabolism of lipids. Baillieres Clin Gastroenterol 1998;12:671-696.
19. Beath S, Hooley, Willis K, et al: Long chain triacylglycerol malabsorption and pancreatic function in children with protein energy malnutrition complicating severe liver disease. Proc Nutr Soc 1993;52:252A.
20. Bach AC, Babayan V: Medium-chain triglycerides: an update. Am J Clin Nutr 1982;36:950-962.
21. Kaufman SS, Murray ND, Wood RP, et al: Nutritional support for the infants with extrahepatic biliary atresia. J Pediatr 1987;10:679-685.
22. Rebouche CJ, Panagides DD, Nelson SE: Role of carnitine in utilization of dietary medium-chain triglycerides by term infants. Am J Clin Nutr 1990;52:820-824.
23. Kaufmann SS, Scrivner DJ, Murray ND, et al: Influence of portagen and pregestimil on essential fatty acid status in infantile liver disease. Pediatrics 1992;89:151-154.
24. Bach A, Schirardin H, Bauer M, Weryha A: Ketogenic response to medium-chain triglyceride load in the rat. J Nutr 1977;107:1863-1870.
25. Beath SV, Johnson S, Willis KD, et al: Growth and luminal fat solubilisation in cholestatic infants on medium chain triglyceride (MCT). J Pediatr Gastroenterol Nutr 1996;22:443.
26. Koletzko B, Agostoni C, Carlson SE, et al: Long chain polyunsaturated fatty acids (LC-PUFA) and perinatal development. Acta Paediatr 2001;90:460-464.
27. Koletzko B: Fats for brains. Eur J Clin Nutr 1992;46:S51-S62.
28. Demmelmair H, von Schenck U, Behrendt E, et al: Estimation of arachidonic acid synthesis in full term neonates using natural variation of C13 content. J Pediatr Gastroenterol Nutr 1995;21:31-36.
29. Simmer K: Longchain polyunsaturated fatty acid supplementation in infants born at term (Cochrane Review); in The Cochrane Library, Issue 3. Cichester, Wiley, 2004.
30. Uauy R, Hoffman DR, Mena P, et al: Term infant studies of DHA and ARA supplementation on neurodevelopment: results of randomized controlled trials. J Pediatr 2003;143:S17-S25.
31. Birch EE, Hoffman DR, Castañeda YS, et al: A randomized controlled trial of long-chain polyunsaturated fatty acid supplementation of formula in term infants after weaning at 6 wk of age. Am J Clin Nutr 2002;75:570-580.
32. Hoffman DR, Birch EE, Castañeda YS, et al: Visual function in breast-fed term infants weaned to formula with or without long-chain polyunsaturates at 4 to 6 months: a randomized clinical trial. J Pediatr 2003;142:669-677.
33. Field CJ, Van Aerde JE, Robinson LE, Clandinin MT: Effect of providing a formula supplemented with long-chain polyunsaturated fatty acids on immunity in full-term neonates. Br J Nutr 2008;99:91-99.
34. Levy J, DeFelice A, Lepage G: Essential fatty acid deficiency mimicking porphyria cutanea tarda in a patient with chronic cholestasis. J Pediatr Gastroenterol Nutr 1990;10:242-245.
35. Socha P, Koletzko B, Świa̧tkowska E, et al: Essential fatty acid metabolism in infants with cholestasis. Acta Pediatr 1998;87:278-283.
36. Socha P, Koletzko B, Pawlowska P, Socha J: Essential fatty acid status in children with cholestasis, in relation to serum bilirubin concentration. J Pediatr 1997;131:700-706.
37. Socha P, Koletzko B, Pawlowska J, et al: Treatment of cholestatic children with water-soluble vitamin E (alpha-tocopheryl polyethylene glycol succinate): effects on serum vitamin E, lipid peroxides, and polyunsaturated fatty acids. J Pediatr Gastroenterol Nutr 1997;24:189-193.
38. Socha P, Koletzko B, ?wi?tkowska E, et al: Essential fatty acid metabolism in infants with cholestasis. Acta Pediatr 1998;87:278-283.
39. Lapillonne A, Hakme C, Mamoux V, et al: Effects of liver transplantation on long-chain polyunsaturated fatty acid status in infants with biliary atresia. J Pediatr Gastroenterol Nutr 2000;30:528-532.
40. Hochman J, Balistreri WF: Neonatal cholestasis: differential diagnosis, evaluation and management; in Balistreri WF, Ohi R, Todani T, Tsuchida Y (eds): Hepatobiliary, Pancreatic and Splenic Disease in Children. Amsterdam, Elsevier, 1997.
41. Amedée-Manesme O, Furr HC, Alvarez F, et al: Biochemical indicators of vitamin A depletion in children with cholestasis. Hepatology 1985;5:1143-1148.
42. Gumpricht E, Dahl R, Devereaux MW, Sokol RJ: β-Carotene prevents bile acid-induced cytotoxicity in rat hepatocyte: evidence for an antioxidant and anti-apoptotic role of β-carotene in vitro. Pediatr Res 2004;55:814-821.
43. Leon AM, Ahmed S, Aleynik SI, et al: Carotenoids and tocopherols in various hepatobiliary conditions. J Hepatol 1995;23:550-556.
44. Argao EA, Specker BL, Heubi JE: Bone mineral content in infants and children with chronic cholestatic liver disease. Pediatrics 1993;91:1151-1154.
45. Argao EA, Balistreri WF, Hollis BW, et al: Effect of orthotopic liver transplantation on bone mineral content and serum vitamin D metabolites in infants and children with chronic cholestasis. Hepatology 1994;20:598-603.
46. Anderson CM, Townley RR, Freeman JP: Unusual causes of steatorrhea in infancy and childhood. Med J Aust 1961;11:617-621.
47. Nasr SZ, O'Leary MH, Hillermeier C: Correction of vitamin E deficiency with fat-soluble versus water-miscible preparations of vitamin E in patients with cystic fibrosis. J Pediatr 1993;122:810-812.
48. Sokol RJ, Kayden HJ, Bettis DB, et al: Isolated vitamin E deficiency in the absence of fat malabsorption - familial and sporadic cases: characterization and investigations of causes. J Lab Clin Med 1988;11:548-559.
49. Sokol RJ, Butler-Simon N, Conner C, et al: Multicenter trial of d-M-tocopheryl polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis. Gastroenterology 1993;104:1727-1735.
50. Sokol RJ, Heubi JE, Butler-Simon N, et al: Treatment of vitamin E deficiency during chronic childhood cholestasis with oral d-T-tocopheryl polyethylene glycol-1000-succinate. Gastroenterology 1987;93:975-985.
51. Sokol RJ, Guggenheim MA, Iannaccone ST, et al: Improved neurologic function following long-term correction of vitamin E deficiency in children with chronic cholestasis. N Engl J Med 1985;313:1580-1586.
52. Argao EA, Heubi JE: Fat-soluble vitamin deficiency in infants and children. Curr Opin Pediatr 1993;5:562-566.
53. van Hasselt PM, de Koning TJ, Kvist N, et al: The Netherlands Study Group for Biliary Atresia Registry. Prevention of vitamin K deficiency bleeding in breastfed infants: lessons from the Dutch and Danish biliary atresia registries. Pediatrics 2008;121:e857-e863.
54. 1 in children with cholestasis. J Pediatr Gastroenterol Nutr 1992;14:160-165.
55. Bonkovsky HL, Banner BF, Lambrecht RW, Rubin RB: Iron in liver diseases other than haemochromatosis. Semin Liver Dis 1996;16:65-82.
56. Wierzbicka A, Paw?owska J, Socha P, et al: Lipid, carbohydrate metabolism, and antioxidant status in children after liver transplantation. Transplant Proc 2007;39:1523-1525.
57. Plauth M, Merli M, Weimann A, et al: ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr 1997;16:43-45.
58. Socha P, Koletzko B, Demmelmair H, et al: Short-term effects of parenteral nutrition of cholestatic infants with lipid emulsions based on medium-chain and long-chain triacylglycerols. Nutrition 2007;23:121-126.
59. Guimber D, Michaud L, Ategbo S, et al: Experience of parenteral nutrition for nutritional rescue in children with severe liver disease following failure of enteral nutrition. Pediatr Transplant 1999;3:139-145.